vs
CSG SYSTEMS INTERNATIONAL INC（CSGS）とPrivia Health Group, Inc.（PRVA）の財務データ比較。上の社名をクリックして会社を切り替えられます
Privia Health Group, Inc.の直近四半期売上が大きい（$541.2M vs $323.1M、CSG SYSTEMS INTERNATIONAL INCの約1.7倍）。CSG SYSTEMS INTERNATIONAL INCの純利益率が高く（2.2% vs 1.7%、差は0.5%）。Privia Health Group, Inc.の前年同期比売上増加率が高い（17.4% vs 2.0%）。過去8四半期でPrivia Health Group, Inc.の売上複合成長率が高い（14.2% vs 4.6%）
中国南玻集団股フン有限公司は中国最大級の建築用ガラスメーカーで、浮きガラス、建築用ガラス、ディスプレイ用ガラス、自動車用ガラス、コーティングガラス、鏡、カラーフィルターガラス、太陽光発電用ガラス、省エネガラスなど多種多様なガラス製品の製造・販売を手がけています。
Privia Health Group, Inc.は米国に本拠を置く医療テクノロジー・サービス企業で、独立診療所、医療システム、保険者向けに価値基準型医療の実践を支援します。人口健康管理ツール、患者エンゲージメント基盤、ケア調整支援、業務フロー最適化ソリューションを提供し、診療成果の向上と運用コスト削減を促します。
CSGS vs PRVA — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $323.1M | $541.2M |
| 純利益 | $7.0M | $9.2M |
| 粗利率 | 50.0% | — |
| 営業利益率 | 9.0% | 2.1% |
| 純利益率 | 2.2% | 1.7% |
| 売上前年比 | 2.0% | 17.4% |
| 純利益前年比 | -79.7% | 108.0% |
| EPS（希薄化後） | $0.24 | $0.08 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $323.1M | $541.2M | ||
| Q3 25 | $303.6M | $580.4M | ||
| Q2 25 | $297.1M | $521.2M | ||
| Q1 25 | $299.5M | $480.1M | ||
| Q4 24 | $316.7M | $460.9M | ||
| Q3 24 | $295.1M | $437.9M | ||
| Q2 24 | $290.3M | $422.3M | ||
| Q1 24 | $295.1M | $415.2M |
| Q4 25 | $7.0M | $9.2M | ||
| Q3 25 | $20.5M | $6.9M | ||
| Q2 25 | $12.3M | $2.7M | ||
| Q1 25 | $16.1M | $4.2M | ||
| Q4 24 | $34.5M | $4.4M | ||
| Q3 24 | $19.1M | $3.5M | ||
| Q2 24 | $13.8M | $3.5M | ||
| Q1 24 | $19.5M | $3.0M |
| Q4 25 | 50.0% | — | ||
| Q3 25 | 48.1% | — | ||
| Q2 25 | 49.5% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 51.3% | — | ||
| Q3 24 | 49.4% | — | ||
| Q2 24 | 47.3% | — | ||
| Q1 24 | 46.5% | — |
| Q4 25 | 9.0% | 2.1% | ||
| Q3 25 | 10.0% | 2.5% | ||
| Q2 25 | 10.0% | 0.6% | ||
| Q1 25 | 9.8% | 1.1% | ||
| Q4 24 | 13.4% | 1.1% | ||
| Q3 24 | 10.8% | 1.3% | ||
| Q2 24 | 8.8% | 1.2% | ||
| Q1 24 | 10.8% | 0.2% |
| Q4 25 | 2.2% | 1.7% | ||
| Q3 25 | 6.7% | 1.2% | ||
| Q2 25 | 4.1% | 0.5% | ||
| Q1 25 | 5.4% | 0.9% | ||
| Q4 24 | 10.9% | 1.0% | ||
| Q3 24 | 6.5% | 0.8% | ||
| Q2 24 | 4.8% | 0.8% | ||
| Q1 24 | 6.6% | 0.7% |
| Q4 25 | $0.24 | $0.08 | ||
| Q3 25 | $0.73 | $0.05 | ||
| Q2 25 | $0.44 | $0.02 | ||
| Q1 25 | $0.57 | $0.03 | ||
| Q4 24 | $1.20 | $0.03 | ||
| Q3 24 | $0.67 | $0.03 | ||
| Q2 24 | $0.48 | $0.03 | ||
| Q1 24 | $0.68 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.0M | $479.7M |
| 総負債低いほど良い | $539.5M | — |
| 株主資本純資産 | $283.7M | $737.2M |
| 総資産 | $1.5B | $1.4B |
| 負債/資本比率低いほどレバレッジが低い | 1.90× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $180.0M | $479.7M | ||
| Q3 25 | $158.4M | $441.4M | ||
| Q2 25 | $145.9M | $390.1M | ||
| Q1 25 | $136.0M | $469.3M | ||
| Q4 24 | $161.8M | $491.1M | ||
| Q3 24 | $118.4M | $422.0M | ||
| Q2 24 | $110.4M | $387.4M | ||
| Q1 24 | $120.8M | $351.1M |
| Q4 25 | $539.5M | — | ||
| Q3 25 | $538.6M | — | ||
| Q2 25 | $537.8M | — | ||
| Q1 25 | $537.6M | — | ||
| Q4 24 | $538.5M | — | ||
| Q3 24 | $539.5M | — | ||
| Q2 24 | $540.5M | — | ||
| Q1 24 | $541.5M | — |
| Q4 25 | $283.7M | $737.2M | ||
| Q3 25 | $289.5M | $709.1M | ||
| Q2 25 | $290.7M | $682.9M | ||
| Q1 25 | $283.1M | $659.4M | ||
| Q4 24 | $282.6M | $635.2M | ||
| Q3 24 | $288.4M | $614.9M | ||
| Q2 24 | $273.3M | $595.4M | ||
| Q1 24 | $269.3M | $576.8M |
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.5B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.3B | $1.0B |
| Q4 25 | 1.90× | — | ||
| Q3 25 | 1.86× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 1.91× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 2.01× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $59.2M | $127.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $55.8M | — |
| FCFマージンFCF / 売上 | 17.3% | — |
| 設備投資強度設備投資 / 売上 | 1.1% | — |
| キャッシュ転換率営業CF / 純利益 | 8.46× | 13.93× |
| 直近12ヶ月FCF直近4四半期 | $141.4M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $59.2M | $127.5M | ||
| Q3 25 | $47.9M | $52.0M | ||
| Q2 25 | $37.3M | $8.0M | ||
| Q1 25 | $11.5M | $-24.1M | ||
| Q4 24 | $82.5M | $74.8M | ||
| Q3 24 | $39.5M | $33.2M | ||
| Q2 24 | $43.1M | $34.5M | ||
| Q1 24 | $-29.4M | $-33.1M |
| Q4 25 | $55.8M | — | ||
| Q3 25 | $43.9M | — | ||
| Q2 25 | $34.6M | — | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $76.6M | — | ||
| Q3 24 | $32.0M | — | ||
| Q2 24 | $38.8M | — | ||
| Q1 24 | $-34.1M | — |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 2.4% | — | ||
| Q4 24 | 24.2% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | -11.6% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 8.46× | 13.93× | ||
| Q3 25 | 2.34× | 7.58× | ||
| Q2 25 | 3.04× | 2.97× | ||
| Q1 25 | 0.71× | -5.70× | ||
| Q4 24 | 2.39× | 17.00× | ||
| Q3 24 | 2.07× | 9.38× | ||
| Q2 24 | 3.12× | 9.94× | ||
| Q1 24 | -1.51× | -11.10× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSGS
| Software As A Service And Related Solutions | $287.2M | 89% |
| License And Service | $22.6M | 7% |
| Maintenance | $13.3M | 4% |
PRVA
| FFS Patient Care | $364.4M | 67% |
| Capitated Revenue | $71.4M | 13% |
| Shared Savings | $46.9M | 9% |
| FFS Administrative Services | $36.0M | 7% |
| Care Management Fee PMPM | $20.0M | 4% |
| Other Revenue | $2.5M | 0% |
